TcLand gains gene expression patents for autoimmune disease testing
This article was originally published in Clinica
Executive Summary
French biomarker specialist TcLand Expression has secured exclusive licences to gene expression patents from the private-sector technology transfer subsidiary of the French National Institute for Health and Medical Research (Inserm).